Literature DB >> 1783522

Effects of benzoylphenyl ureas on growth of B16 melanoma cells in vitro and in vivo.

H P Hofs1, J G McVie.   

Abstract

New analogs of diflubenzuron, a benzoylphenyl urea, are tested on their in vitro cytostatic activity against B16 melanoma cells. The following structure-activity relationship was established: substitution by a hydroxylated function at the ortho, meta or para position or by a dimethylamino function at the ortho position of the benzoyl moiety appeared to be necessary for cytostatic activity in vitro. Acetoxy functions at the ortho position or hydroxy functions at the para position of the aniline ring resulted also in active compounds. A number of these benzoylphenyl ureas are selected for in vivo evaluation of antitumor activity on B16 melanoma growing s.c.. Although many of the tested benzoylphenyl ureas delayed tumor growth during the first ten days of drug treatment, only a few increased animal life span. The best results (% T/C) were obtained with compounds 5 (127%), 7 (147%), 13 (135%) and 16 (135%), which all have hydroxylated functions in the benzoyl moiety.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1783522     DOI: 10.1007/bf00176975

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  12 in total

1.  The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.

Authors:  R P Hill; J A Stanley
Journal:  Cancer Res       Date:  1975-05       Impact factor: 12.701

2.  Consideration of the subcutaneously implanted B16 melanoma as a screening model for potential anticancer agents.

Authors:  D P Griswold
Journal:  Cancer Chemother Rep 2       Date:  1972-11

3.  Effects of diflubenzuron on growth of malignant melanoma and skin carcinoma tumors in mice.

Authors:  V K Jenkins; R T Mayer; R R Perry
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

4.  Structure-activity relationship of 1-propargyl-5-halopyrimidin-2-ones. Metaphase arresting properties and competitive inhibition of colchicine binding to tubulin.

Authors:  J M Dornish; R Oftebro
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

5.  The use of tumor growth kinetics in planning "curative" chemotherapy of advanced solid tumors.

Authors:  F M Schabel
Journal:  Cancer Res       Date:  1969-12       Impact factor: 12.701

6.  Synthesis and mode(s) of action of a new series of imide derivatives of 3-nitro-1,8 naphthalic acid.

Authors:  M F Braña; J M Castellano; C M Roldán; A Santos; D Vázquez; A Jiménez
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

7.  Inhibition of cellular proliferation of imaginal epidermal cells by diflubenzuron in pupae of the stable fly.

Authors:  S M Meola; R T Mayer
Journal:  Science       Date:  1980-02-29       Impact factor: 47.728

8.  Inhibition of melanogenesis in B16-F1 melanoma cells after exposure to diflubenzuron.

Authors:  J O Norman; S M Meola
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

9.  Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.

Authors:  L H Li; T L Wallace; K A Richard; D E Tracey
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

10.  Synthesis and biological properties of side-chain-modified bleomycins.

Authors:  W J Vloon; C Kruk; U K Pandit; H P Hofs; J G McVie
Journal:  J Med Chem       Date:  1987-01       Impact factor: 7.446

View more
  1 in total

1.  Quantitative Structure-Cytotoxic Activity Relationship 1-(Benzoyloxy)urea and Its Derivative.

Authors:  Suko Hardjono; Siswandono Siswodihardjo; Purwanto Pramono; Win Darmanto
Journal:  Curr Drug Discov Technol       Date:  2016
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.